Begoña Vilar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Begoña Vilar has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Laura Guío Carrión
Servicio de Enfermedades Infecciosas, Hospital Universitario Cruces, Barakaldo, España
2 shared publications Amaia Lopez
1 shared publicationAne Gibelalde
Hospital Donostia
1 shared publication- Angel Zaballos
Genomics Unit, Core Scientific and Technical Units, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
1 shared publication - Borja Gomez
Pediatric Emergency Department Cruces University Hospital Barakaldo Spain
1 shared publication Bárbara Berasategui
Cruces Hospital
1 shared publication
Latest Publications
- 10 August 2026
- Published by Sociedad Espanola de Quimioterapia in Revista Española de Quimioterapia
- Vol. 39 (5) , 409
Artritis gonocócica, ni tan frecuente ni tan sencilla. Descripción clínica de casos diagnosticados en el norte de España entre 2013 y 2023
Introducción: Ante el aumento actual de la incidencia de la infección por Neisseria gonorrhoeae, cabe esperar asimismo un incremento de las formas diseminadas de la enfermedad. Dentro de la enfermedad gonocócica diseminada, la artritis gonocócica presenta peculiaridades clínicas, diagnósticas y terapéuticas. Métodos: Se realizó una búsqueda retrospectiva de muestras de líquido articular con resultado positivo para N. gonorrhoeae mediante cultivo o técnicas de biología molecular entre 2013 y 2023 en varios hospitales del norte de España. Posteriormente, se realizó un análisis descriptivo. Resultados: Se analizaron 15 pacientes. La monoartritis fue la presentación más frecuente (60 %), seguida de la poliartritis, con afectación predominante de la muñeca o la rodilla. Las artralgias o la tenosinovitis en otras localizaciones, especialmente en la muñeca, fueron frecuentes. La identificación microbiológica se realizó mediante cultivo convencional (12/14) o PCR (7/7). En el 30 % de los casos fue necesaria la evacuación ecoguiada repetida o la limpieza quirúrgica. La duración media de la antibioterapia intravenosa fue de 12 días y la de la antibioterapia total, de 22 días. La respuesta fue favorable en todos los casos. Conclusión: En el contexto actual de incremento de la incidencia de la infección gonocócica, en los pacientes con monoartritis o poliartritis séptica y tenosinovitis concomitante, especialmente con afectación radiocarpiana, debe considerarse la posibilidad de artritis gonocócica. Las técnicas de biología molecular pueden ser relevantes para la identificación de N. gonorrhoeae en casos sospechosos. La evolución clínica puede ser variable y requerir limpieza quirúrgica y tratamientos más prolongados.
- 10 August 2026
- Published by Sociedad Espanola de Quimioterapia in Revista Española de Quimioterapia
- Vol. 39 (5) , 409
Artritis gonocócica, ni tan frecuente ni tan sencilla. Descripción clínica de casos diagnosticados en el norte de España entre 2013 y 2023
Introducción: Ante el aumento actual de la incidencia de la infección por Neisseria gonorrhoeae, cabe esperar asimismo un incremento de las formas diseminadas de la enfermedad. Dentro de la enfermedad gonocócica diseminada, la artritis gonocócica presenta peculiaridades clínicas, diagnósticas y terapéuticas. Métodos: Se realizó una búsqueda retrospectiva de muestras de líquido articular con resultado positivo para N. gonorrhoeae mediante cultivo o técnicas de biología molecular entre 2013 y 2023 en varios hospitales del norte de España. Posteriormente, se realizó un análisis descriptivo. Resultados: Se analizaron 15 pacientes. La monoartritis fue la presentación más frecuente (60 %), seguida de la poliartritis, con afectación predominante de la muñeca o la rodilla. Las artralgias o la tenosinovitis en otras localizaciones, especialmente en la muñeca, fueron frecuentes. La identificación microbiológica se realizó mediante cultivo convencional (12/14) o PCR (7/7). En el 30 % de los casos fue necesaria la evacuación ecoguiada repetida o la limpieza quirúrgica. La duración media de la antibioterapia intravenosa fue de 12 días y la de la antibioterapia total, de 22 días. La respuesta fue favorable en todos los casos. Conclusión: En el contexto actual de incremento de la incidencia de la infección gonocócica, en los pacientes con monoartritis o poliartritis séptica y tenosinovitis concomitante, especialmente con afectación radiocarpiana, debe considerarse la posibilidad de artritis gonocócica. Las técnicas de biología molecular pueden ser relevantes para la identificación de N. gonorrhoeae en casos sospechosos. La evolución clínica puede ser variable y requerir limpieza quirúrgica y tratamientos más prolongados.
- Open Access
- 16 November 2017
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 5 (46) , e01212-17
First Insight into the Genome Sequences of Two Linezolid-Resistant Nocardia farcinica Strains Isolated from Patients with Cystic Fibrosis
The draft genome sequences of two Nocardia farcinica strains isolated from two patients with cystic fibrosis (CF), resistant to trimethoprim/sulfamethoxazole and linezolid, are reported here. The estimated genome sizes were 5.8 Mb with a 70.63% G+C content. Transposases from Tn 916 were detected, but not 23S rRNA mutation (G2576T) related to linezolid resistance.
- 16 November 2017
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 5 (46) , e01212-17
Open AccessFirst Insight into the Genome Sequences of Two Linezolid-Resistant Nocardia farcinica Strains Isolated from Patients with Cystic Fibrosis
The draft genome sequences of two Nocardia farcinica strains isolated from two patients with cystic fibrosis (CF), resistant to trimethoprim/sulfamethoxazole and linezolid, are reported here. The estimated genome sizes were 5.8 Mb with a 70.63% G+C content. Transposases from Tn 916 were detected, but not 23S rRNA mutation (G2576T) related to linezolid resistance.
- 1 May 2015
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 34 (5) , 494-498
Prevalence and Predictors of Bacterial Meningitis in Young Infants With Fever Without a Source
Classical criteria differ when performing cerebrospinal fluid (CSF) analysis in infants younger than 90 days with fever without a source (FWS). Our objectives were to analyze the prevalence and microbiology of bacterial meningitis in this group and its prevalence in relation to clinical and laboratory risk factors. This is a substudy of a prospective registry including all infants of this age with FWS seen between September 2003 and August 2013 in a Pediatric Emergency Department of a Tertiary Teaching Hospital. Lumbar puncture was performed in 639 (27.0%) of the 2362 infants with FWS seen, the rate being higher in not well-appearing infants [60.9% vs. 25.7%; odds ratio (OR), 4.49] and in those ≤21 days old (70.1% vs. 20.4%; OR, 9.14). Eleven infants were diagnosed with bacterial meningitis: 9 were ≤21 days old (prevalence 2.8% vs. 0.1%; OR, 30.42) and 5 were not well-appearing infants (5.7% vs. 0.2%; OR, 23.06). Bacteria isolated were Streptococcus agalactiae (3), Escherichia coli (3), Listeria monocytogenes (3), Streptococcus pneumoniae (1) and Neisseria meningitidis (1). None of the 1975 well-appearing infants >21 days old were diagnosed with bacterial meningitis, regardless of whether biomarkers were altered. In infants younger than 90 days with FWS, performing CSF analysis for ruling out bacterial meningitis must be strongly considered in not well-appearing infants and in those ≤21 days old. The recommendation of systematically performing CSF analysis in well-appearing infants 22-90 days of age on the basis of analytical criteria alone must be reevaluated.
- 1 May 2015
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 34 (5) , 494-498
Prevalence and Predictors of Bacterial Meningitis in Young Infants With Fever Without a Source
Classical criteria differ when performing cerebrospinal fluid (CSF) analysis in infants younger than 90 days with fever without a source (FWS). Our objectives were to analyze the prevalence and microbiology of bacterial meningitis in this group and its prevalence in relation to clinical and laboratory risk factors. This is a substudy of a prospective registry including all infants of this age with FWS seen between September 2003 and August 2013 in a Pediatric Emergency Department of a Tertiary Teaching Hospital. Lumbar puncture was performed in 639 (27.0%) of the 2362 infants with FWS seen, the rate being higher in not well-appearing infants [60.9% vs. 25.7%; odds ratio (OR), 4.49] and in those ≤21 days old (70.1% vs. 20.4%; OR, 9.14). Eleven infants were diagnosed with bacterial meningitis: 9 were ≤21 days old (prevalence 2.8% vs. 0.1%; OR, 30.42) and 5 were not well-appearing infants (5.7% vs. 0.2%; OR, 23.06). Bacteria isolated were Streptococcus agalactiae (3), Escherichia coli (3), Listeria monocytogenes (3), Streptococcus pneumoniae (1) and Neisseria meningitidis (1). None of the 1975 well-appearing infants >21 days old were diagnosed with bacterial meningitis, regardless of whether biomarkers were altered. In infants younger than 90 days with FWS, performing CSF analysis for ruling out bacterial meningitis must be strongly considered in not well-appearing infants and in those ≤21 days old. The recommendation of systematically performing CSF analysis in well-appearing infants 22-90 days of age on the basis of analytical criteria alone must be reevaluated.
- 1 October 2014
- Published by Elsevier in Medicina Clinica
- Vol. 143 (7) , 331-332
Absceso cerebral por Actinomyces meyeri
- 1 October 2014
- Published by Elsevier in Medicina Clinica
- Vol. 143 (7) , 331-332
Absceso cerebral por Actinomyces meyeri
- 29 January 2012
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 14 (2) , 137-146
Dacryocystitis: Systematic Approach to Diagnosis and Therapy
The objective of this paper is to review the main findings of the largest studies on the etiopathogenesis and microbiology of the development of dacryocystitis and to formulate clinical and surgical guidelines based on said studies and on our experience at Cruces Hospital, the Basque Country, Spain. The most common sign of this entity is the distal nasolacrimal duct obstruction, and this should be treated to prevent clinical relapse. The time when surgery should be indicated mainly depends on the clinical signs and symptoms, age and general status of a patient. Given the germs isolated in cases of dacryocystitis, antibiotic therapy against Gram positive (S. aureus, S. pneumoniae, S. epidermidis) and Gram negative bacteria (H. influenzae, P. aeruginosa) should be administered, orally in adults and intravenously in pediatric patients, prior to surgery. Gentamicin and amoxicillin-clavulanic acid have been found to be effective against the bacteria commonly implicated in the etiopathogenesis of this entity.
- 29 January 2012
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 14 (2) , 137-146
Dacryocystitis: Systematic Approach to Diagnosis and Therapy
The objective of this paper is to review the main findings of the largest studies on the etiopathogenesis and microbiology of the development of dacryocystitis and to formulate clinical and surgical guidelines based on said studies and on our experience at Cruces Hospital, the Basque Country, Spain. The most common sign of this entity is the distal nasolacrimal duct obstruction, and this should be treated to prevent clinical relapse. The time when surgery should be indicated mainly depends on the clinical signs and symptoms, age and general status of a patient. Given the germs isolated in cases of dacryocystitis, antibiotic therapy against Gram positive (S. aureus, S. pneumoniae, S. epidermidis) and Gram negative bacteria (H. influenzae, P. aeruginosa) should be administered, orally in adults and intravenously in pediatric patients, prior to surgery. Gentamicin and amoxicillin-clavulanic acid have been found to be effective against the bacteria commonly implicated in the etiopathogenesis of this entity.